SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-16-000072
Filing Date
2016-08-08
Accepted
2016-08-08 16:23:55
Documents
45
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq22016.htm 10-Q 609660
2 EXHIBIT 31.1 exhibit311q22016.htm EX-31.1 13286
3 EXHIBIT 32.1 exhibit321q22016.htm EX-32.1 6851
  Complete submission text file 0001561743-16-000072.txt   3401193

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT kin-20160630.xml EX-101.INS 796349
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20160630.xsd EX-101.SCH 23029
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20160630_cal.xml EX-101.CAL 44169
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20160630_def.xml EX-101.DEF 101645
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20160630_lab.xml EX-101.LAB 316873
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20160630_pre.xml EX-101.PRE 180638
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 161814444
SIC: 2834 Pharmaceutical Preparations